Résumé
In 2018, the Department of Clinical Pharmacy (DPC) opened a second centralized preparation unit for injectable chemotherapies (UCPC) sized to treat an increasing flow of preparations: 52,000 preparations in 2008 versus 80,000 in 2020. To meet the growing demand for preparations, the UCPC was enlarged in 2018 with a new controlled atmosphere area equipped with 2 ApotecaChemo robots (Loccioni) with a production start-up in February and October 2018 respectively. They increased production capacity, safety and robustness accounting for 40 up to 50% of our total daily production. In 2020, the DPC decided to acquire a third robot to increase robotic production and manage ever more complex preparations, especially for the pediatric activity. The selection criteria for this call for tenders are summarized in this analysis.
Titre traduit de la contribution | Criteria for choosing a robot for injectable chemotherapy preparations |
---|---|
langue originale | Français |
Pages (de - à) | 81-87 |
Nombre de pages | 7 |
journal | Journal de Pharmacie Clinique |
Volume | 40 |
Numéro de publication | 2 |
Les DOIs | |
état | Publié - 1 juin 2021 |
mots-clés
- Call for tender
- Compounding robot
- Criteria selection
- Injectable anticancer drugs